In a rare move, a group of bipartisan lawmakers from the House and Senate joined forces Thursday to demand greater transparency about what the government pays for certain drugs — and to offer legislation toward that end.
Trending:
Lawmakers ask Medicaid if it needs more power to fix drug misclassifications